DCF — BAPTIST MEDICAL CENTER SOUTH
Enterprise Value: $-513.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-513.7M
Enterprise Value
$-172.3M
PV of Cash Flows
$-341.3M
PV of Terminal Value
$-549.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $613.3M | $-26.6M | -4.0% | $-52.6M | $-47.8M |
| Year 2 | $631.7M | $-21.1M | -3.0% | $-47.9M | $-39.6M |
| Year 3 | $650.7M | $-15.3M | -2.0% | $-42.8M | $-32.2M |
| Year 4 | $670.2M | $-12.4M | -2.0% | $-40.7M | $-27.8M |
| Year 5 | $690.3M | $-11.0M | -2.0% | $-40.2M | $-25.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-513.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$595.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04844247531493307
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5